You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Title |
The Global Innovation Model for Antibiotics Needs Reinvention
|
---|---|
Published in |
The Journal of Law, Medicine & Ethics, January 2021
|
DOI | 10.1111/jlme.12270 |
Pubmed ID | |
Authors |
Manica Balasegaram, Charles Clift, John-Arne Røttingen |
Abstract |
The dangers presented by antibiotic resistance (ABR) have now established themselves as a global health security issue. From an international policy perspective, three key pillars have been established - responsible access, conservation, and innovation. These pillars are intrinsically linked, meaning that any attempt to address one, must take into account the implications for the other two. This article attempts to address all three of these pillars. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 22 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 18% |
Student > Master | 3 | 14% |
Student > Doctoral Student | 2 | 9% |
Other | 2 | 9% |
Librarian | 2 | 9% |
Other | 6 | 27% |
Unknown | 3 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 18% |
Arts and Humanities | 2 | 9% |
Social Sciences | 2 | 9% |
Biochemistry, Genetics and Molecular Biology | 2 | 9% |
Agricultural and Biological Sciences | 2 | 9% |
Other | 6 | 27% |
Unknown | 4 | 18% |